Pharma
As Novo’s patent expires, GLP-1 generics go global
Cheaper options may grant many more patients worldwide access to GLP-1s.
Drug Pricing
Latest news and analysis on drug pricing from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Pharma
GoodRx, Eli Lilly launch direct-to-employer models that reduce reliance on PBMs
Is direct to employer the new direct to consumer?
Pharma
Big Pharma tackles Super Bowl advertising
This year’s game was punctuated by more pharma commercials, though some experts wonder if regulations might squash that momentum.
Pharma
GLP-1 manufacturers enter a turf war
The girls are fighting…again.
Pharma
Mark Cuban chats drug costs with Scripta
Cuban shares “the biggest lie” in pharmacy.
Pharma
These biotechs launched DTC platforms to take part in TrumpRx. But do stakeholders care?
Experts don’t expect a huge difference in drug prices for patients.
Pharma
What’s TrumpRx, and how does it compare to other DTC options?
Experts say it’s not so different from existing choices, like drug discount company Cost Plus Drugs.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
